Comaneci 17
Payments companies reported to CMS as associated with Comaneci 17. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Comaneci 17, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Comaneci 17
These are the largest totals companies reported as associated with Comaneci 17. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Edgar Samaniego | Iowa City, IA | Vascular & Interventional Radiology | $97,565.94 |
| Justin Singer | Grand Rapids, MI | Neurological Surgery | $73,437.57 |
| Rishi Gupta | Marietta, GA | Neurological Surgery | $66,430.26 |
| Erez Nossek | New York, NY | Neurological Surgery | $63,834.54 |
| Shahram Majidi | New York, NY | Neurological Surgery | $43,893.26 |
| Benjamin Yim | Walnut Creek, CA | Neurological Surgery | $34,204.90 |
| Sudhakar Satti | Paoli, PA | Neuroradiology | $28,055.81 |
| Geoffrey Colby | Los Angeles, CA | Neurological Surgery | $25,961.79 |
| Sudipta Roychowdhury | East Brunswick, NJ | Neuroradiology | $24,696.96 |
| Satoshi Tateshima | Los Angeles, CA | Vascular & Interventional Radiology | $20,660.81 |
Prescribed Comaneci 17?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.